BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12594894)

  • 1. Can one use biologic modifiers to prevent multiple organ dysfunction syndrome after abdominal infections?
    Dellinger EP
    Surg Infect (Larchmt); 2000; 1(3):239-47; discussion 247-8. PubMed ID: 12594894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of multiple organ dysfunction syndrome--endotoxin, inflammatory cells, and their mediators: cytokines and reactive oxygen species.
    Maier RV
    Surg Infect (Larchmt); 2000; 1(3):197-204; discussion 204-5. PubMed ID: 12594890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIRS, MODS and tertiary peritonitis.
    Reemst PH; van Goor H; Goris RJ
    Eur J Surg Suppl; 1996; (576):47-8; discussion 49. PubMed ID: 8908471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of multiple organ dysfunction syndrome: gut origin, protection, and decontamination.
    Rotstein OD
    Surg Infect (Larchmt); 2000; 1(3):217-23; discussion 223-5. PubMed ID: 12594892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of translocation.
    Van Leeuwen PA; Boermeester MA; Houdijk AP; Ferwerda CC; Cuesta MA; Meyer S; Wesdorp RI
    Gut; 1994 Jan; 35(1 Suppl):S28-34. PubMed ID: 8125386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome.
    Wang H; Ma S
    Am J Emerg Med; 2008 Jul; 26(6):711-5. PubMed ID: 18606328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of antibiotic treatment in surgical infections of the abdomen. At what point is infection cured but inflammation persists?
    Pollock AV
    Eur J Surg Suppl; 1996; (576):13-5. PubMed ID: 8908462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous transplantation of endothelial progenitor cells to prevent multiple organ dysfunction syndromes in pig.
    Tianhang L; Bo W; Zhengmao L; Tao P; Hong Z; Xuchao X; Jianwei B; Hui Z; Guoen F
    J Trauma Acute Care Surg; 2013 Feb; 74(2):508-15. PubMed ID: 23147181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular changes in association with defense mechanisms in intra-abdominal sepsis.
    Pavlidis TE
    Minerva Chir; 2003 Dec; 58(6):777-81. PubMed ID: 14663404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From acute pancreatitis to end-organ injury: mechanisms of acute lung injury.
    De Campos T; Deree J; Coimbra R
    Surg Infect (Larchmt); 2007 Feb; 8(1):107-20. PubMed ID: 17381402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathophysiological mechanisms of organ dysfunction in sepsis].
    Calderari B; Liaudet L
    Rev Med Suisse; 2010 Dec; 6(275):2406-9. PubMed ID: 21268420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytokine storm in the pathogenesis of multiple organ dysfunction syndrome associated with surgical insults].
    Aikawa N
    Nihon Geka Gakkai Zasshi; 1996 Sep; 97(9):771-7. PubMed ID: 8940690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The innate immune response to secondary peritonitis.
    van Till JW; van Veen SQ; van Ruler O; Lamme B; Gouma DJ; Boermeester MA
    Shock; 2007 Nov; 28(5):504-17. PubMed ID: 17589378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunological aspects of postoperative sepsis].
    Beloborodova NV; Bachinskaia EN
    Anesteziol Reanimatol; 2000; (1):59-66. PubMed ID: 10769474
    [No Abstract]   [Full Text] [Related]  

  • 15. Gut Microbiota and Multiple Organ Dysfunction Syndrome (MODS).
    Chen P; Billiar T
    Adv Exp Med Biol; 2020; 1238():195-202. PubMed ID: 32323186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple organ dysfunction syndrome: past, present and future.
    Fry DE
    Surg Infect (Larchmt); 2000; 1(3):155-61; discussion 161-3. PubMed ID: 12594886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR9+ macrophages are required for eradication of peritoneal bacterial infections and prevention of polymicrobial sepsis.
    Mizukami T; Kanai T; Mikami Y; Hayashi A; Doi T; Handa T; Matsumoto A; Jun L; Matsuoka K; Sato T; Hisamatsu T; Hibi T
    Immunol Lett; 2012 Sep; 147(1-2):75-9. PubMed ID: 22771342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory therapy for sepsis: an update.
    Christaki E; Anyfanti P; Opal SM
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1013-33. PubMed ID: 22029521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a new extracorporeal system using CTR on mortality and inflammatory responses to bacterial toxin-induced multiple organ dysfunction syndrome in rabbits.
    Kawatsu M; Wada J; Kitano M; Ogino E; Sakurai H; Furuyoshi S; Tani N
    Blood Purif; 2006; 24(3):327-34. PubMed ID: 16534195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory responses and mediators.
    Kim PK; Deutschman CS
    Surg Clin North Am; 2000 Jun; 80(3):885-94. PubMed ID: 10897267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.